Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Bank of America Co. 

West Pharmaceutical Services Inc. diskutieren

West Pharmaceutical Services Inc.

WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Aktie / Ausrüstung & Versorgung / Mid Cap /

273,30 €
-0,73 %

17 0
17
0

West Pharmaceutical Services (NYSE:WST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for WST provided by MarketBeat

Evercore ISI 
0
Melden Teilen
03.02.26 Buy 36,24 %

West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for WST provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
10.02.26 Buy 29,59 %

West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Ratings data for WST provided by MarketBeat

Deutsche Bank Aktiengesellschaft 
0
Melden Teilen
13.02.26 Buy 30,95 %

West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for WST provided by MarketBeat

UBS Group AG 
0
Melden Teilen
13.02.26 Buy 30,95 %

West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for WST provided by MarketBeat

Evercore Inc. 
0
Melden Teilen
24.04.26 Buy 3,33 %

West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for WST provided by MarketBeat

Citigroup Inc. 
0
Melden Teilen
24.04.26 Buy 5,68 %

West Pharmaceutical Services (WST) was upgraded by Zacks Research from "hold" to "strong-buy".
Ratings data for WST provided by MarketBeat

Zacks Research 
0
Melden Teilen
15.05.26 Buy 6,18 %
Einschätzung Buy
Rendite (%) 1,56 %
Kursziel 309,35
Veränderung
Endet am 02.06.27

West Pharmaceutical Services (WST) had its "overweight" rating reaffirmed by Stephens. They now have a $360.00 price target on the stock.
Ratings data for WST provided by MarketBeat

Stephens 
0
Melden Teilen
02.06.26

West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Wolfe Research.
Ratings data for WST provided by MarketBeat

Wolfe Research 
0
Melden Teilen
03.06.26 Buy 0,81 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

StockNews_com in AbbVie Inc. diskutieren
AbbVie (ABBV) was downgraded by Wall Street Zen from "str...
15:00
StockNews_com in Broadcom Ltd. diskutieren
Broadcom (AVGO) was upgraded by Wall Street Zen from "hol...
15:00
StockNews_com in Cardinal Health Inc. diskutieren
Cardinal Health (CAH) was upgraded by Wall Street Zen fro...
15:00
StockNews_com in Dover Corp. diskutieren
Dover (DOV) was upgraded by Wall Street Zen from "hold" t...
15:00
StockNews_com in J.B. Hunt Transport Services Inc. diskutieren
J.B. Hunt Transport Services (JBHT) was upgraded by Wall ...
15:00
StockNews_com in Proto Labs Inc. diskutieren
Proto Labs (PRLB) was upgraded by Wall Street Zen from "b...
15:00
StockNews_com in China Telecom Corp. Ltd. ADR diskutieren
Chagee (CHA) was upgraded by Wall Street Zen from "hold" ...
06.06.26
Zacks_Research in ASML Holding N.V. ADR diskutieren
ASML (ASML) was upgraded by Zacks Research from "hold" to...
06.06.26
Mehr anzeigen